Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.2739
+0.0039 (1.44%)
At close: Oct 9, 2025, 4:00 PM EDT
0.1641
-0.1098 (-40.09%)
Pre-market: Oct 10, 2025, 9:04 AM EDT
Carisma Therapeutics Market Cap
Carisma Therapeutics has a market cap or net worth of $11.45 million as of October 10, 2025. Its market cap has decreased by -71.67% in one year.
Market Cap
11.45M
Enterprise Value
11.15M
1-Year Change
-71.67%
Ranking
Category
Stock Price
$0.27
Market Cap Chart
Since February 6, 2014, Carisma Therapeutics's market cap has decreased from $159.40M to $11.45M, a decrease of -92.82%. That is a compound annual growth rate of -20.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 11.40M | -34.86% |
| Dec 31, 2024 | 17.50M | -85.19% |
| Dec 29, 2023 | 118.20M | -4.37% |
| Dec 30, 2022 | 123.60M | -23.99% |
| Dec 31, 2021 | 162.60M | -6.87% |
| Dec 31, 2020 | 174.60M | 60.33% |
| Dec 31, 2019 | 108.90M | -1.00% |
| Dec 31, 2018 | 110.00M | 326.36% |
| Dec 29, 2017 | 25.80M | -44.28% |
| Dec 30, 2016 | 46.30M | -21.53% |
| Dec 31, 2015 | 59.00M | -69.51% |
| Dec 31, 2014 | 193.50M | 21.39% |
| Feb 6, 2014 | 159.40M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 764.45B |
| Johnson & Johnson | 457.10B |
| AbbVie | 410.12B |
| UnitedHealth Group | 336.01B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 265.74B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 234.13B |